FourWorld Capital Management’s Neuronetics STIM Stock Holding History

FourWorld Capital Management’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.27M	Buy	1,744,142 +254,820	+17%	+$371K	2.06%	17
2026 Q1	$2.16M	Buy	1,489,322 +558,072	+60%	+$885K	1.1%	16
2025 Q4	$1.29M	Buy	931,250 +363,250	+64%	+$760K	1.04%	15
2025 Q3	$1.55M	Buy	568,000 +68,000	+14%	+$242K	2.45%	11
2025 Q2	$1.75M	Hold	500,000	–	–	1.17%	11
2025 Q1	$1.84M	Sell	500,000 -358,107	-42%	-$1.31M	1.18%	8
2024 Q4	$1.38M	Buy	858,107 +353,550	+70%	+$368K	0.72%	7
2024 Q3	$383K	Buy	504,557 +482,736	+2,212%	+$634K	0.22%	18
2024 Q2	$39.3K	Sell	21,821 -14,100	-39%	-$40.7K	0.02%	30
2024 Q1	$171K	Buy	+35,921	New	+$126K	0.11%	29

Other funds holding STIM

MAM

Madryn Asset Management New York $36.9M AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return

Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

MCM

Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

FourWorld Capital Management's STIM Position: Q2 2026 in Review

FourWorld Capital Management increased its Neuronetics (STIM) stake by 17% in Q2 2026, buying an estimated $371K and bringing the position to 1,744,142 shares worth $2.27M. The position accounts for 2.06% of the portfolio, ranked #17.

FourWorld Capital Management first reported a position in STIM in Q1 2024 and has held it in 10 quarters since. 87 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

FourWorld Capital Management held 1,744,142 shares of Neuronetics worth $2.27M as of Q2 2026.
FourWorld Capital Management bought 254,820 Neuronetics shares in Q2 2026, an estimated $371K.
Neuronetics made up 2.06% of FourWorld Capital Management's portfolio in Q2 2026, its #17 holding.
FourWorld Capital Management first reported a position in Neuronetics in Q1 2024 and has held it in 10 quarters since.
87 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on FourWorld Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.